Back to REGN
Bronte Capital Management Pty Ltd. → REGN
Bronte Capital Management Pty Ltd. REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
8
Latest value
$52M
Q3 2026
Peak value
$136.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $136.4M |
| Q4 2025 | $45.8M |
| Q1 2026 | $133.5M |
| Q1 2026 | $53M |
| Q2 2026 | $101.4M |
| Q2 2026 | $42.8M |
| Q3 2026 | $125.2M |
| Q3 2026 | $52M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $52M | 68.6K | — | — |
| Q3 2026 | $125.2M | 165.1K | — | — |
| Q2 2026 | $42.8M | 68.6K | — | — |
| Q2 2026 | $101.4M | 162.6K | — | — |
| Q1 2026 | $53M | 68.6K | — | — |
| Q1 2026 | $133.5M | 172.8K | — | — |
| Q4 2025 | $45.8M | 59.3K | — | — |
| Q4 2025 | $136.4M | 176.8K | — | — |